Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
3/6 of the 9 checks — 3 couldn't be scored (see above), so the score is out of the 6 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 29% of free cash flow, leaving room to grow it and fund buybacks. Last year: $73M dividends + $110M buybacks = $183M returned on $255M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 15%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.6M 100.0% | $13.1M 100.0% | $12.5M 100.0% | $11.13B 100.0% | $9.47B 100.0% | — | — | $4.22B 100.0% | $3.90B 100.0% | $1.21B 100.0% |
| Research & Development | $76.7M 565.5% | $496.7M 3801.8% | $511.0M 4072.4% | $491.5M 4.4% | $434.9M 4.6% | $370.2M | $390.6M | $318.0M 7.5% | $164.9M 4.2% | — |
| Selling, General & Admin | $63.2M 465.9% | $413.5M 3165.1% | $390.0M 3108.4% | $401.7M 3.6% | $518.2M 5.5% | $461.1M | $435.8M | $383.4M 9.1% | $423.8M 10.9% | $237.8M 19.7% |
| Total Operating Expenses | $1.52B 11229.7% | $10.53B 80597.3% | $10.16B 81001.0% | $8.62B 77.4% | $6.86B 72.4% | $5.26B | $3.32B | $2.70B 63.9% | $2.40B 61.6% | $978.9M 81.0% |
| Interest Expense | $4.1M 30.0% | — | $53.1M 423.3% | $146.3M 1.3% | $73.8M 0.8% | $228.3M | $235.6M | $60.1M 1.4% | $15.6M 0.4% | $18.2M 1.5% |
| Other Income (Expense), net | $31.0M 228.3% | $310.1M 2373.5% | $394.7M 3145.6% | $220.7M 2.0% | $122.4M 1.3% | $116.5M | $136.5M | $148.4M 3.5% | $36.5M 0.9% | $13.7M 1.1% |
| Pretax Income | $443.5M 3268.4% | $2.85B 21776.3% | $2.78B 22144.6% | $2.74B 24.6% | $2.74B 28.9% | $2.42B | $2.86B | $2.62B 62.1% | $1.36B 34.8% | $549.8M 45.5% |
| Income Tax Expense | $79.5M 586.2% | $457.4M 3500.8% | $395.1M 3148.8% | $454.8M 4.1% | $240.8M 2.5% | $455.4M | $482.0M | $151.2M 3.6% | $274.7M 7.1% | $48.3M 4.0% |
| Net Income | $363.6M 2679.2% | $2.38B 18239.5% | $2.34B 18655.9% | $2.27B 20.4% | $2.51B 26.5% | $1.97B | $2.37B | $2.47B 58.5% | $1.08B 27.8% | $501.5M 41.5% |
| Per Share | ||||||||||
| EPS (Basic) | $0.29 | $1.85 | $1.70 | $1.60 | $1.77 | $1.34 | $1.56 | $1.65 | $-2.55 | $-0.09 |
| EPS (Diluted) | $0.27 | $1.81 | $1.67 | $1.56 | $1.69 | $1.32 | $1.53 | $1.54 | $-2.55 | $-0.09 |
| Weighted Avg Shares (Basic) | 1.26B | 1.29B | 1.37B | 1.41B | 1.42B | 1.48B | 1.53B | 1.50B | 779.8M | 665.0M |
| Weighted Avg Shares (Diluted) | 1.33B | 1.32B | 1.40B | 1.45B | 1.48B | 1.49B | 1.55B | 1.60B | 779.8M | 665.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
No current price collected.
Nothing notable to watch.
Where each multiple sits in its own 9-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 9-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| R&D | 7.5 | — | — | 4.6 | 4.4 | 4072.4 | 3801.8 | 565.5 |
| SG&A | 9.1 | — | — | 5.5 | 3.6 | 3108.4 | 3165.1 | 465.9 |
| Income Tax | 3.6 | — | — | 2.5 | 4.1 | 3148.8 | 3500.8 | 586.2 |
| Net Income | 58.5 | — | — | 26.5 | 20.4 | 18655.9 | 18239.5 | 2679.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on FINV: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~10.9% on $37M of debt.
Cash of $613M fully covers short-term debt of $24M.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.